1. Home
  2. STTK vs NMG Comparison

STTK vs NMG Comparison

Compare STTK & NMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$6.90

Market Cap

538.3M

Sector

Health Care

ML Signal

HOLD

Logo Nouveau Monde Graphite Inc.

NMG

Nouveau Monde Graphite Inc.

HOLD

Current Price

$1.61

Market Cap

473.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
NMG
Founded
2016
2011
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Metals and Minerals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
538.3M
473.9M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
STTK
NMG
Price
$6.90
$1.61
Analyst Decision
Buy
Strong Buy
Analyst Count
7
2
Target Price
$10.00
$5.75
AVG Volume (30 Days)
1.8M
789.0K
Earning Date
05-01-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
53.02
N/A
EPS
N/A
N/A
Revenue
$1,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$1.37
52 Week High
$8.33
$6.06

Technical Indicators

Market Signals
Indicator
STTK
NMG
Relative Strength Index (RSI) 64.10 49.29
Support Level $5.81 $1.39
Resistance Level $7.68 $1.64
Average True Range (ATR) 0.58 0.07
MACD 0.28 0.02
Stochastic Oscillator 84.39 89.80

Price Performance

Historical Comparison
STTK
NMG

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About NMG Nouveau Monde Graphite Inc.

Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The Company currently operates in two segments: the Mining projects (which includes the Matawinie Mine project and the Uatnan Mining Project) and the Battery Material Plant project.

Share on Social Networks: